JPMorgan Chase & Co. Has $7.76 Million Stake in U.S. Physical Therapy, Inc. (NYSE:USPH)

JPMorgan Chase & Co. grew its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 26.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 87,501 shares of the company's stock after acquiring an additional 18,484 shares during the period. JPMorgan Chase & Co. owned 0.58% of U.S. Physical Therapy worth $7,762,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. CBIZ Investment Advisory Services LLC grew its position in U.S. Physical Therapy by 59.8% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after buying an additional 122 shares in the last quarter. Venturi Wealth Management LLC raised its stake in U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after acquiring an additional 704 shares in the last quarter. Pacer Advisors Inc. bought a new position in shares of U.S. Physical Therapy in the fourth quarter worth about $113,000. Mutual of America Capital Management LLC bought a new position in U.S. Physical Therapy in the 4th quarter valued at approximately $203,000. Finally, KLP Kapitalforvaltning AS acquired a new stake in shares of U.S. Physical Therapy during the 4th quarter valued at $257,000.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. StockNews.com downgraded shares of U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research report on Thursday, April 17th. William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. JPMorgan Chase & Co. decreased their target price on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. JMP Securities restated a "market outperform" rating and issued a $113.00 price target on shares of U.S. Physical Therapy in a research report on Tuesday. Finally, Barrington Research decreased their price objective on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, U.S. Physical Therapy currently has an average rating of "Moderate Buy" and a consensus target price of $109.00.

Insider Activity

In related news, COO Graham D. Reeve sold 1,730 shares of U.S. Physical Therapy stock in a transaction on Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the sale, the chief operating officer now owns 7,168 shares of the company's stock, valued at approximately $588,564.48. This trade represents a 19.44 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.70% of the company's stock.

U.S. Physical Therapy Trading Up 2.2 %

USPH stock traded up $1.45 during mid-day trading on Tuesday, reaching $67.76. The company's stock had a trading volume of 86,875 shares, compared to its average volume of 106,902. The company has a market cap of $1.03 billion, a price-to-earnings ratio of 72.09, a price-to-earnings-growth ratio of 3.54 and a beta of 1.38. U.S. Physical Therapy, Inc. has a 12 month low of $62.77 and a 12 month high of $108.14. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The business's 50 day moving average price is $75.69 and its 200 day moving average price is $84.59.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company had revenue of $180.45 million for the quarter, compared to the consensus estimate of $173.10 million. On average, equities research analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 14th were paid a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 2.66%. The ex-dividend date was Friday, March 14th. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.44. U.S. Physical Therapy's dividend payout ratio (DPR) is 97.83%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.